WWWei Wang

Wei Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wei Wang has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Research Progress of Coumarins in the Genus Angelica

    by Xin‐Zhuo Li, Miao‐Miao Xu, Hao‐Nan Xu, Yu‐Ze Li, Chong Deng, Xiao‐Mei Song, Dong‐Dong Zhang, Wei Wang

    Angelica L., a genus in the Apiales family, has about 110 species that have been found in the world, which includes 52 different therapeutic herbs in addition to Angelica sinensis , Angelica dahurica , and Angelica pubescens , is rich in medicinal plant resources and is widely dispersed. It has a great therapeutic potential and is frequently used in clinical practice as a type of bulk medicinal herb. As traditional medicinal plants, many kinds of Angelica plants possess medicinal value, such as the customary benefits of blood tonification, blood circulation stimulation, menstrual regulation, pain relief, laxative action, antiaging, antioxidant, analgesic, anti‐inflammatory, and antitumor properties. The coumarins in Angelica are the fundamental source of the medicinal properties, according to contemporary studies. To provide references for the next in‐depth study of Angelica coumarins, the chemical structures and pharmacological effects were examined through a compilation of pertinent domestic and international literature in this paper.


  • Current research and perspectives of polysaccharides in flowers: A review

    by Yuxuan Wang, Haonan Xu, Jiayi Zhang, Chuanming Gong, Yuying Zhang, Yuze Li, Xiaomei Song, Wei Wang, Dongdong Zhang


  • Botanical, Phytochemistry, Pharmacology and Applications of Genus Aframomum: A Review

    by Dongdong Zhang, Yezi Ma, Haonan Xu, Yu Sun, Hao Fan, Yuze Li, Xiaomei Song, Wei Wang

    Aframomum belongs to the ginger family Zingiberaceae, a group of perennial herbaceous plants found mainly in tropical Africa, including many countries in West, Central and East Africa. Aframomum spp has a long history of medicinal use in African traditional medicine. It has been used to treat a variety of ailments such as digestive disorders (for relief of indigestion, stomach pains, etc.), respiratory disorders (to alleviate symptoms of coughs and colds), and inflammatory diseases. However, there is a lack of current literature summarizing this area. Therefore, the present review aims to comprehensively organize the botanical, phytochemical, and pharmacological studies of Aframomum spp to provide reference studies for further discovery of its therapeutic value. For this purpose, relevant information on Aframomum spp was searched from scientific databases including Science Direct, Web of Science, Google Scholar, PubMed. Modern studies have shown that Aframomum spp contains a variety of chemical constituents containing terpenoids, diarylheptanoids, flavonoids, and lignans, which have various pharmacological effects such as antioxidant, antibacterial, anti-inflammatory and analgesic. The phytoconstituents and various pharmacological activities of Aframomum spp. reported in this paper can provide valuable references for further studies.


  • Exploring cadmium uptake pathways in the roots of Coptis chinensis Franch

    by Yuting Niu, Shuang He, Lu Xing, Dongdong Zhang, Yuze Li, Chong Deng, Yi Jiang, Huawei Zhang, Xiaomei Song, Meihai Ding, et al.

    To investigate the cadmium (Cd) uptake mechanism in the roots of Coptis chinensis Franch., we utilized non-invasive micro-test technology (NMT) to analyze Cd2+ and H+ fluxes, alongside ICP-MS to assess Cd content and fluxes under various inhibitors and ion channel blockers. Results revealed that Cd2+ uptake primarily occurs in the root meristematic zone. Cd2+ addition significantly inhibited H+ influx. The P-type ATPase inhibitor Na3VO4 and the metabolism inhibitor CCCP both reduced Cd2+ fluxes and Cd content in roots of C. chinensis Ca2+ channel blocker LaCl3 exhibited more pronounced inhibition on Cd2+ flux than K+ channel blocker TEA, indicating Cd2+ uptake mainly via Ca2+ channels. Therefore, active transport and Ca2+ channels may play an important role in Cd uptake in C. chinensis roots.


  • Epimedium Linn: A Comprehensive Review of Phytochemistry, Pharmacology, Clinical Applications and Quality Control

    by Xiao‐Lin Chen, Shi‐Xing Li, Teng Ge, Dong‐Dong Zhang, Hai‐Fang Wang, Wei Wang, Yu‐Ze Li, Xiao‐Mei Song

    Epimedium genus is a traditional Chinese medicine, which has functions of tonifying kidney and yang, strengthening tendons and bones, dispelling wind and emoving dampness. It is mainly used for the treatment of impotence and spermatorrhea, osteoporosis, Parkinson's, Alzheimer's, and cardiovascular diseases. The aim of this review is to provide a systematic summary of the phytochemistry, pharmacology, and clinical applications of the Epimedium Linn. In this paper, the relevant literature on Epimedium Linn. was collected from 1987 to the present day, and more than 274 chemical constituents, including flavonoids, phenylpropanoids, lignans, phenanthrenes, and others, were isolated from this genus. Modern pharmacological studies have shown that Epimedium Linn. has osteoprotective, neuroprotective, cardiovascular protective, and immune enhancing pharmacological effects. In addition, Epimedium Linn. has been commonly used to treat osteoporosis, erectile dysfunction, hypertension and cardiovascular disease. In this paper, the distribution of resources, chemical compositions, pharmacological effects, clinical applications and quality control of Epimedium Linn. are progressed to provide a reference for further research and development of the resources of this genus.


  • Curcumae Radix: A Review of Traditional Use, Phytochemistry, Pharmacology, Toxicology and Quality Control

    by Yu‐Ting Niu, Hao‐Nan Xu, Yu‐Ying Zhang, Xin‐Zhuo Li, Yu‐Ze Li, Xiao‐Mei Song, Dong‐Dong Zhang, Wei Wang

    Curcumae Radix (CuR) is a traditional Chinese medicine that has been used in China for more than 1,000 years. It has the traditional efficacy of activating blood and relieving pain, promoting qi and relieving depression, clearing heart and cooling blood, and promoting gallbladder and removing jaundice. Based on this, many domestic and foreign scholars have conducted systematic studies on its chemical composition, pharmacological effects, toxicity and quality control. Currently, 250 compounds, mainly including terpenoids and curcuminoids, have been isolated and identified from CuR, which has pharmacological activities, including antitumor, anti‐inflammatory and analgesic, antidepressant, hepatoprotective, hemostatic, hematopoietic, and treatment of diabetes mellitus. In modern clinical practice, CuR is widely used in the treatment of tumors, breast hyperplasia, hepatitis, and stroke. However, the generation of toxicity and clinical application of CuR and Caryophylli Flos, the determination of the concoction process of artifacts, the determination of specific Quality Marker, and the establishment of the quality control system of CuR, are problems that need to be solved urgently at present.


  • Top Cited Papers

    Astragali Radix: comprehensive review of its botany, phytochemistry, pharmacology and clinical application

    by Ya-Xiao Liu, Xiao-Mei Song, Lin-Wei Dan, Jia-Mei Tang, Yi Jiang, Chong Deng, Dong-Dong Zhang, Yu-Ze Li, Wei Wang

    Astragali Radix (A. Radix) is the dried root of Astragalus membranaceus var. mongholicus (Bge) Hsiao or Astragalus membranaceus (Fisch.) Bge., belonging to the family Leguminosae, which is mainly distributed in China. A. Radix has been consumed as a tonic in China for more than 2000 years because of its medicinal effects of invigorating the spleen and replenishing qi. Currently, more than 400 natural compounds have been isolated and identified from A. Radix, mainly including saponins, flavonoids, phenylpropanoids, alkaloids, and others. Modern pharmacological studies have shown that A. Radix has anti-tumor, anti-inflammatory, immunomodulatory, anti-atherosclerotic, cardioprotective, anti-hypertensive, and anti-aging effects. It has been clinically used in the treatment of tumors, cardiovascular diseases, and cerebrovascular complications associated with diabetes with few side effects and high safety. This paper reviewed the progress of research on its chemical constituents, pharmacological effects, clinical applications, developing applications, and toxicology, which provides a basis for the better development and utilization of A. Radix.


  • Botany, Traditional Use, Phytochemistry, Pharmacology and Clinical Applications of Rhubarb (Rhei Radix et Rhizome): A Systematic Review

    by Haonan Xu, Wei Wang, Xinzhuo Li, Yuze Li, Yi Jiang, Chong Deng, Xiaomei Song, Dongdong Zhang

    Rhubarb, the Rhei radix et rhizoma (Da huang) is a member of the Polygonaceae family, included in the 2020 edition of the Chinese Pharmacopoeia, and is mainly distributed in Gansu, Sichuan, Qinghai, northwestern Yunnan, and eastern Tibet. Rhei radix et rhizoma is one of the most commonly used traditional Chinese medicines, processed into drinkable tablets in different concoctions for clinical use. Phytochemical studies showed that more than 170 compounds were isolated and identified from Rhei radix et rhizoma, including anthraquinones/anthrones (major constituents), stilbenes, chromones, flavonoids, tannins, and other compounds, etc. Rhei radix et rhizoma is an herb with a long history of traditional use and many potential therapeutic benefits. It can play the role of diarrhea, clearing heat in response to different combinations and concoctions. It is mainly used for the treatment of constipation, gastrointestinal function impairment, and other diseases. In addition, Rhei radix et rhizoma has significant antitumor, anti-inflammatory, antibacterial, hepato-renal protective, neuroprotective, hypolipidemic, and immunomodulatory activities. Its active constituents have anti-tumor, anti-inflammatory, anti-inflammatory and hepato-kidney protective properties. Although it is primarily used for gastrointestinal disorders, it may also have wider applications in various inflammatory and liver disorders. Therefore, further studies are needed to explore its full potential and mechanism of action. This paper reviews the research progress of Rhei radix et rhizoma in terms of botany, traditional use, chemistry, pharmacology, and clinical studies. It aims to provide a scientific basis for in-depth research and development of Rhei radix et rhizome resources.


  • A Review of Extraction and Purification, Biological Properties, Structure–Activity Relationships and Future Prospects of Schisandrin C: A Major Active Constituent of Schisandra Chinensis

    by Hao‐Nan Xu, Wei Wang, Xin‐Zhuo Li, Yu Sun, Yu‐Ze Li, Chong Deng, Xiao‐Mei Song, Dong‐Dong Zhang

    Since ancient times, China has used natural medicine as the primary way to combat diseases and has a rich arsenal of natural medicines. With the progress of the times, the extraction of bioactive molecules from natural drugs has become the new development direction for natural medicines. Among the numerous natural drugs, Schisandrin C (Sch C), derived from Schisandra Chinensis (Turcz.) Baill. It has excellent potential for development and has been shown to possess various pharmacological properties, including hepatoprotective, antitumor and anti‐inflammatory activities. Based on the biological properties of hepatoprotection, scholars have explored Sch C and its synthetic products in depth; some studies have shown that pentosidine has the effect of improving the symptoms of liver fibrosis and reducing the concentration of alanine transaminase (ALT) and aspartate aminotransferase (AST) in the serum of rats, which is an essential inspiration for the development of anti‐liver fibrosis drugs. But more in vivo and ex vivo studies still need to be included. This paper focuses on Sch C′s extraction and synthesis, biological activities and drug development progress. The future application prospects of Sch C are discussed to perfect its development work further.


  • Traditional Use, Pharmacology and Toxicology of the Lignans in Genus Kadsura: A Systematic Review

    by Dongdong Zhang, Haonan Xu, Wei Wang, Xinzhuo Li, Yuze Li, Yi Jiang, Xiaomei Song, Chong Deng

    The genus Kadsura is an important part of traditional Chinese medicine, it has the functions of promoting wind, eliminating dampness, activating blood circulation. Modern pharmacological studies have shown that lignans are one of the main components to possess these medicinal effects. This review aimed to provide a systematic summary on the traditional use, phytochemistry, pharmacology, toxicology and other aspects of lignans in genus Kadsura. In this paper, we collected the relevant literature on Kadsura lignans from 1973 to the present, and isolated more than 337 lignans from this genus, including dibenzocyclooctadienes, aryltetralins, tetrahydrofurans, diarylbutanes, 7,8-seco-lignans, bisepoxylignans, neolignans, seco-dibenzocyclooctadienes, sesquilignan and coumarin-containing lignan. Previous pharmacological studies have shown that lignans of the genus Kadsura have antitumor, anti-inflammatory, antibacterial, anti-HIV, anti-platelet aggregation, immunomodulatory and antioxidant effects. In clinical practice, it is commonly used to treat Alzheimer's disease, inflammation and insomnia. Kadsura is an important part of the field of Chinese medicine and is widely used in traditional medicine. However, further clarification of its active ingredients and mechanism of action and the establishment of a complete quality standard system are needed in order to provide a scientific basis for in-depth studies of this genus.